The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Kuebler Christopher A since year 2005.
The trader's CIK number is 1229877.
At the time of this reporting, Kuebler Christopher A is the Director of Waters Corp /de/ .
(stock ticker symbol WAT).
See this page for all insider trading activities at Waters Corp /de/ .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-03-09 | WAT | Waters Corp /de/ | Sale | 7,084 | 209.10 | 1,481,264 |
| 2018-03-09 | WAT | Waters Corp /de/ | Option Ex | 7,084 | 49.86 | 353,208 |
| 2018-03-08 | WAT | Waters Corp /de/ | Option Ex | 416 | 61.63 | 25,638 |
| 2018-03-08 | WAT | Waters Corp /de/ | Sale | 416 | 209.00 | 86,944 |
| 2018-03-06 | NKTR | Nektar Therapeutics | Option Ex | 2,600 | 5.14 | 13,364 |
| 2018-03-07 | NKTR | Nektar Therapeutics | Option Ex | 37,400 | 7.19 | 268,906 |
| 2018-03-06 | NKTR | Nektar Therapeutics | Sale | 2,600 | 100.30 | 260,780 |
| 2018-03-07 | NKTR | Nektar Therapeutics | Sale | 37,400 | 97.41 | 3,643,134 |
| 2018-01-02 | NKTR | Nektar Therapeutics | Sale | 30,000 | 58.66 | 1,759,800 |
| 2018-01-02 | NKTR | Nektar Therapeutics | Option Ex | 30,000 | 14.26 | 427,800 |
| 2017-09-22 | NKTR | Nektar Therapeutics | Sale | 4,000 | 21.86 | 87,440 |
| 2017-08-08 | WAT | Waters Corp /de/ | Option Ex | 3,500 | 76.75 | 268,625 |
| 2017-08-08 | WAT | Waters Corp /de/ | Sale | 3,500 | 179.67 | 628,845 |
| 2017-04-05 | NKTR | Nektar Therapeutics | Option Ex | 15,000 | 8.37 | 125,549 |
| 2017-04-05 | NKTR | Nektar Therapeutics | Sale | 15,000 | 21.88 | 328,200 |
| 2016-09-15 | NKTR | Nektar Therapeutics | Option Ex | 15,000 | .00 | 0 |
| 2016-09-16 | NKTR | Nektar Therapeutics | Sale | 7,500 | 19.13 | 143,475 |
| 2016-05-04 | WAT | Waters Corp /de/ | Option Ex | 4,000 | 48.88 | 195,520 |
| 2016-05-04 | WAT | Waters Corp /de/ | Sale | 4,000 | 129.88 | 519,520 |
| 2015-12-04 | NKTR | Nektar Therapeutics | Option Ex | 15,000 | 5.15 | 77,250 |
| 2015-12-04 | NKTR | Nektar Therapeutics | Sale | 15,000 | 15.82 | 237,300 |
| 2015-11-23 | WAT | Waters Corp /de/ | Option Ex | 4,000 | 44.25 | 177,000 |
| 2015-11-23 | WAT | Waters Corp /de/ | Sale | 4,000 | 133.17 | 532,680 |
| 2015-01-13 | NKTR | Nektar Therapeutics | Sale | 15,000 | 16.00 | 240,000 |
| 2015-01-13 | NKTR | Nektar Therapeutics | Option Ex | 15,000 | 8.81 | 132,150 |
| 2013-08-05 | NKTR | Nektar Therapeutics | Option Ex | 12,500 | 11.41 | 142,625 |
| 2013-08-05 | NKTR | Nektar Therapeutics | Sale | 12,500 | 12.41 | 155,125 |
| 2012-09-27 | NKTR | Nektar Therapeutics | Option Ex | 12,500 | 8.66 | 108,250 |
| 2012-09-27 | NKTR | Nektar Therapeutics | Sale | 12,500 | 10.66 | 133,250 |
| 2011-03-07 | NKTR | Nektar Therapeutics | Option Ex | 10,000 | .00 | 0 |
| 2008-11-14 | NKTR | Nektar Therapeutics | Option Ex | 5,000 | .00 | 0 |
| 2005-03-21 | CVD | Covance Inc | Sale | 17,271 | 45.23 | 781,184 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kuebler Christopher A (Director of Waters Corp /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.